Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1426]
News [2906]
Articles [125]
Editorials [5]
Conferences [153]
elearning [6]
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial...
Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer ( Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA )
27 Feb 2015
New approach to prostate cancer screening
Dr Sanoj Punnen - University of Miami, Miami, USA
New approach to prostate cancer screening ( Dr Sanoj Punnen - University of Miami, Miami, USA )
27 Feb 2015
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma:...
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015
mRCC: Are we doing all we can to manage adverse events?
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
mRCC: Are we doing all we can to manage adverse events? ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015
mRCC: Real-world experience: achieving efficacy beyond clinical trials
Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA
mRCC: Real-world experience: achieving efficacy beyond clinical trials ( Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA )
11 Feb 2015
Optimizing survival in advanced prostate cancer: CHAARTED: What are the...
Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
Optimizing survival in advanced prostate cancer: CHAARTED: What are the implications for the future? ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )
29 Jan 2015
Optimizing Survival in Advanced Prostate Cancer: Conclusion
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing Survival in Advanced Prostate Cancer: Conclusion ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Latest achievements in the p-medicine project
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Latest achievements in the p-medicine project ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
19 Jan 2015
Global cancer and the importance of government engagement
Dr Chris Wild - Director of the International Agency for Research on Cancer
Global cancer and the importance of government engagement ( Dr Chris Wild - Director of the International Agency for Research on Cancer )
18 Dec 2014
Comment: Fulvestrant improves survival over anastrozole for patients with...
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )
16 Dec 2014
Recurrence risk could be predicted by a multigene test in ductal carcinoma...
Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada
Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )
16 Dec 2014
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple...
Dr Rita Nanda - University of Chicago Medicine, Chicago, USA
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )
12 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation